Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 2 min ago
Peer-reviewedCC BY-NC-NDMayo Clinic proceedings. Innovations, quality & outcomes

Sodium–Glucose Cotransporter-2 Inhibitors in World Health Organization Group 1 Pulmonary Arterial Hypertension: A REVEAL Lite 2–Matched Cohort With Time-Varying Exposure Analysis

  • Abdelrahman Hafez1
  • Amal Youssef1
  • Mohamed Nour1
  • Juan M. Farina1
  • Kamal Awad1
  • Milagros Pereyra Pietri1
  • Isabel G. Scalia1
  • Fatmaelzahraa Abdelfattah1
  • Mahshad Razaghi1
  • Laurève Chollet1
  • Sherif Ahmed1
  • Ramzi Ibrahim1
4 more authors
  • Nikita Rafie1
  • Robert L. Scott1
  • Chadi Ayoub1
  • Reza Arsanjani1
  1. 1Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ
Read full textPDFCite

Related

  1. Calcineurin inhibitors treatment in kidney transplant recipients is frequently associated with hyperkalemia, acidosis and hypertension but not with increased expression or phosphorylation of the sodium chloride cotransporter
    Ludovic Di Ascia, Jennifer Baraka-Vidot, Cyril Ferdynus +6
    Frontiers in NephrologyPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaHALPMC
  2. Bile acid dysregulation in pulmonary arterial hypertension: strengthening the liver-lung axis in pulmonary vascular disease
    Vishal N Rao, Kurt W Prins
    American Journal of Respiratory and Critical Care MedicinePeer-reviewedPublisher termsFull textGeneral medicinePMC
  3. β‐sitosterol Alleviates Pulmonary Arterial Hypertension in Rats With Involvement of the VEGF/PI3K/AKT Signaling Pathway
    Xiaobing Wu, Chen Gong, Zhiyu Zeng
    Pulmonary circulationPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Complete transcatheter closure of residual aortopulmonary window in an elderly patient allowing optimization of refractory pulmonary arterial hypertension therapy.
    Yusuke Akazawa, Takashi Higaki, Osamu Yamaguchi
    European heart journal. Case reportsPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCPMC
  5. Patient Perceptions of a Video‐Based Educational Platform for Pulmonary Arterial Hypertension: A Qualitative Study of the SMART‐PAH Course
    Denise G. Sese, Purnadeo Persaud, Lauryn Durham +3
    Pulmonary circulationPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{hafez2026sodiumglucose,
  title = {{Sodium–Glucose Cotransporter-2 Inhibitors in World Health Organization Group 1 Pulmonary Arterial Hypertension: A REVEAL Lite 2–Matched Cohort With Time-Varying Exposure Analysis}},
  author = {Abdelrahman Hafez and Amal Youssef and Mohamed Nour and Juan M. Farina and Kamal Awad and Milagros Pereyra Pietri and Isabel G. Scalia and Fatmaelzahraa Abdelfattah and Mahshad Razaghi and Laurève Chollet and Sherif Ahmed and Ramzi Ibrahim and Nikita Rafie and Robert L. Scott and Chadi Ayoub and Reza Arsanjani},
  journal = {Mayo Clinic proceedings. Innovations, quality \& outcomes},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13718806},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Sodium–Glucose Cotransporter-2 Inhibitors in World Health Organization Group 1 Pulmonary Arterial Hypertension: A REVEAL Lite 2–Matched Cohort With Time-Varying Exposure Analysis
AU  - Abdelrahman Hafez
AU  - Amal Youssef
AU  - Mohamed Nour
AU  - Juan M. Farina
AU  - Kamal Awad
AU  - Milagros Pereyra Pietri
AU  - Isabel G. Scalia
AU  - Fatmaelzahraa Abdelfattah
AU  - Mahshad Razaghi
AU  - Laurève Chollet
AU  - Sherif Ahmed
AU  - Ramzi Ibrahim
AU  - Nikita Rafie
AU  - Robert L. Scott
AU  - Chadi Ayoub
AU  - Reza Arsanjani
PY  - 2026
DA  - 2026/10/21
JO  - Mayo Clinic proceedings. Innovations, quality & outcomes
UR  - https://europepmc.org/article/PMC/PMC13718806
SN  - 2542-4548
ER  -